Insulin resistance and insulin secretion in non-diabetic acromegalic patients. 2007

M Coculescu, and D Niculescu, and R Lichiardopol, and M Purice
Carol Davila University, Endocrinology, Bucharest, Romania. M.Coculescu@uni-davila.ro

Insulin resistance (IR) can be induced by high amounts of growth hormone (GH). OBJECTIVE To set up, in acromegaly without diabetes mellitus, a correlation between the disease activity in GH-secreting adenoma (AA) - assessed by minimum GH serum level during an oral glucose tolerance test (OGTT) - and severity of insulin resistance (IR), assessed by HOMA-IR index. METHODS 75 out of 88 consecutive patients with acromegaly hospitalized in our department were included in this study. 13 patients proved to have diabetes mellitus and were excluded. Serum glucose, GH and insulin levels were measured by immunoradiometricassay basal and at 30, 60 and 120 minutes after a 75 g OGTT in 88 patients with active or cured acromegaly. IR was assessed using HOMA-IR index (Homa-IR=basal serum glucose (mg/dl) x basal serum insulin (mU/L)/22.5 x 18). A value over 2.5 was considered indicating IR. RESULTS Out of 75 patients without diabetes mellitus, 36 subjects (48%) were presenting with IR (34 with active disease, 2 cured). We found a significant positive correlation (r=0.56, p<0.001) between AA and HOMA-IR. The GH minimal level corresponding to the intersection of the exponential regression curve with the HOMA-IR level of 2.5 was 8.8 ng/mL, a cut-off point indicating IR with 82% specificity and 78% sensitivity. The odds ratio for developing IR becomes significant at a minimum GH level during OGTT of 2 ng/mL (odds ratio 7.6, 95% confidence interval 2-29). CONCLUSIONS The severity of IR revealed by acromegaly correlates with GH production. A GH serum level higher than 2 ng/mL during OGTT indicates an increased risk for developing IR. This cut-off level of GH can be used as one of criteria of cured disease, regarding the lack of metabolic effects.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin

Related Publications

M Coculescu, and D Niculescu, and R Lichiardopol, and M Purice
September 1997, Metabolism: clinical and experimental,
M Coculescu, and D Niculescu, and R Lichiardopol, and M Purice
February 1993, Diabetologia,
M Coculescu, and D Niculescu, and R Lichiardopol, and M Purice
July 1975, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
M Coculescu, and D Niculescu, and R Lichiardopol, and M Purice
July 2011, Diabetes research and clinical practice,
M Coculescu, and D Niculescu, and R Lichiardopol, and M Purice
July 1973, La Nouvelle presse medicale,
M Coculescu, and D Niculescu, and R Lichiardopol, and M Purice
January 2007, Kidney international,
M Coculescu, and D Niculescu, and R Lichiardopol, and M Purice
December 2011, Arquivos brasileiros de endocrinologia e metabologia,
M Coculescu, and D Niculescu, and R Lichiardopol, and M Purice
August 1990, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
M Coculescu, and D Niculescu, and R Lichiardopol, and M Purice
March 1995, Acta diabetologica,
M Coculescu, and D Niculescu, and R Lichiardopol, and M Purice
June 2001, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
Copied contents to your clipboard!